Literature DB >> 29484647

Gene-based evaluation of low-frequency variation and genetically-predicted gene expression impacting risk of keloid formation.

Jacklyn N Hellwege1,2, Shirley B Russell2,3, Scott M Williams4, Todd L Edwards1,2, Digna R Velez Edwards2,5.   

Abstract

Keloids are benign dermal tumors occurring approximately 20 times more often in individuals of African descent as compared to individuals of European descent. While most keloids occur sporadically, a genetic predisposition is supported by both familial aggregation of some keloids and large differences in risk among populations. Despite Africans and African Americans being at increased risk over lighter-skinned individuals, little genetic research exists into this phenotype. Using a combination of admixture mapping and exome analysis, we reported multiple common variants within chr15q21.2-22.3 associated with risk of keloid formation in African Americans. Here we describe a gene-based association analysis using 478 African American samples with exome genotyping data to identify genes containing low-frequency variants associated with keloids, with evaluation of genetically-predicted gene expression in skin tissues using association summary statistics. The strongest signal from gene-based association was located in C15orf63 (P-value = 6.6 × 10-6 ) located at 15q15.3. The top result from gene expression was increased predicted DCAF4 expression (P-value = 5.5 × 10-4 ) in non-sun-exposed skin, followed by increased predicted OR10A3 expression in sun-exposed skin (P-value = 6.9 × 10-4 ). Our findings identify variation with putative roles in keloid formation, enhanced by the use of predicted gene expression to support the biological roles of variation identified only though genetic association studies.
© 2018 John Wiley & Sons Ltd/University College London.

Entities:  

Keywords:  African Americans; gene expression; genetic predisposition; keloid; skin

Mesh:

Year:  2018        PMID: 29484647      PMCID: PMC5993571          DOI: 10.1111/ahg.12245

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  51 in total

Review 1.  Keloids--clinical diagnosis, pathogenesis, and treatment options.

Authors:  Alexander G Marneros; Thomas Krieg
Journal:  J Dtsch Dermatol Ges       Date:  2004-11       Impact factor: 5.584

2.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

3.  Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2.

Authors:  Rob Noorlag; Petra van der Groep; Frank K J Leusink; Sander R van Hooff; Michaël H Frank; Stefan M Willems; Robert J J van Es
Journal:  Head Neck       Date:  2014-07-19       Impact factor: 3.147

4.  Epigenetically altered wound healing in keloid fibroblasts.

Authors:  Shirley B Russell; James D Russell; Kathryn M Trupin; Angela E Gayden; Susan R Opalenik; Lillian B Nanney; Alan H Broquist; Latha Raju; Scott M Williams
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

5.  Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.

Authors:  G M Saed; D Ladin; J Olson; X Han; Z Hou; D Fivenson
Journal:  Arch Dermatol       Date:  1998-08

6.  [Keloids on dark skin: a consecutive series of 456 cases].

Authors:  G H Yedomon; H Adegbidi; F Atadokpede; F Akpadjan; E J Mouto; F do Ango-Padonou
Journal:  Med Sante Trop       Date:  2012 Jul-Sep

7.  Altered expression of antimicrobial peptide genes in the skin of dogs with atopic dermatitis and other inflammatory skin conditions.

Authors:  Cheryl A Lancto; Sheila M F Torres; Julie A Hendrickson; Kyra V Martins; Mark S Rutherford
Journal:  Vet Dermatol       Date:  2013-05-24       Impact factor: 1.589

8.  Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.

Authors:  Julia Hentschel; Nele Fischer; Wibke K Janhsen; Udo R Markert; Thomas Lehmann; Jürgen Sonnemann; Klas Böer; Wolfgang Pfister; Uta-Christina Hipler; Jochen G Mainz
Journal:  J Cyst Fibros       Date:  2014-10-05       Impact factor: 5.482

9.  Association study confirmed susceptibility loci with keloid in the Chinese Han population.

Authors:  Fei Zhu; Baoyu Wu; Ping Li; Jianbo Wang; Huayang Tang; Ye Liu; Xianbo Zuo; Hui Cheng; Yantao Ding; Wen Wang; Yujuan Zhai; Fangfang Qian; Wenju Wang; Xiangfeng Yuan; Jing Wang; Weiwei Ha; Junsheng Hou; Fusheng Zhou; Yin Wang; Jinping Gao; Yujun Sheng; Liangdan Sun; Jianjun Liu; Sen Yang; Xuejun Zhang
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

10.  Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment.

Authors:  Willemien Thijs; Kirsten Janssen; Annemarie M van Schadewijk; Socrates E Papapoulos; Saskia le Cessie; Saskia Middeldorp; Christian F Melissant; Klaus F Rabe; Pieter S Hiemstra
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more
  3 in total

1.  Scar Perception: A Comparison of African American and White Self-identified Patients.

Authors:  Stuti P Garg; Abbas M Hassan; Anooj Patel; Deima Koko; Jeffrey Varghese; Marco F Ellis; John Y S Kim; Robert D Galiano
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-05-23

2.  RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing.

Authors:  Jianni Wu; Ester Del Duca; Michael Espino; Alyssa Gontzes; Inna Cueto; Ning Zhang; Yeriel D Estrada; Ana B Pavel; James G Krueger; Emma Guttman-Yassky
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

3.  Perioperative interstitial high-dose-rate brachytherapy for keloids scar.

Authors:  Victoria Vera Barragán; Ana Isabel Alonso García; José Fernández García; Marta De Juan Marín; Johanna Del Carmen Peña Vivas; Germán Juan Rijo
Journal:  J Contemp Brachytherapy       Date:  2022-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.